GlaxoSmithKline PLC (NYSE:GSK)

40.60
Delayed Data
As of Sep 16
 -0.29 / -0.71%
Today’s Change
36.41
Today|||52-Week Range
42.49
+6.25%
Year-to-Date
Glaxo's Asthma Drug Nucala Gets FDA Nod for Pediatric Use
Sep 13 / Zacks.com - Paid Partner Content
Near an All-Time Low, Is Clovis Oncology a Buy?
Sep 04 / MotleyFool.com - Paid Partner Content
Pharma Stock Roundup: Pipeline/Regulatory Updates From GSK, PFE & Others
Sep 13 / Zacks.com - Paid Partner Content
3 International Stocks Worth Watching
Sep 03 / MotleyFool.com - Paid Partner Content
Pfizer is a Top Drugmaker: Is it the Right Time to Buy It?
Sep 06 / Zacks.com - Paid Partner Content